Exiris Exiris
  • About Us
    • Company Profile
    • Management Team
    • Team
    • Board of Directors
    • Scientific Advisors
    • Publications & Patents
  • Technologies
    • Antibody ID
    • Drug Conjugates
    • Cancer Stem Cell
  • Drug Discovery Pipeline
  • Services
    • Platform Technologies
    • Biomarker Discovery
    • Human Skin Equivalents
    • Drug Development Services
  • News
  • Contacts
    • Job Opportunities
Exiris Exiris
  • About Us
    • Company Profile
    • Management Team
    • Team
    • Board of Directors
    • Scientific Advisors
    • Publications & Patents
  • Technologies
    • Antibody ID
    • Drug Conjugates
    • Cancer Stem Cell
  • Drug Discovery Pipeline
  • Services
    • Platform Technologies
    • Biomarker Discovery
    • Human Skin Equivalents
    • Drug Development Services
  • News
  • Contacts
    • Job Opportunities

Exiris a Maker Faire Roma 2024

Exiris partecipa alla Maker Faire Rome dal 25 al 27 ottobre 2024. Vieni a trovarci presso lo stand del Tecnopolo Roma!
  • 21st October 2024
  • News

Interview with Paola Gallinari on “Osservatorio medico-scientifico”

Click here to read the complete interview
  • 27th March 2022
  • News

Exiris @ RaiNews24

RaiNews24, the national TV channel reporting on Italian news, interviews Gessica Filocamo, Exiris Director of Biology Labs, on their pharmaceutical research, as part of the research community of biotech companies... read more →
  • 18th February 2021
  • News

Exiris presents a “High Complexity-High Efficiency Human Antibody Phage Display Library” at the Festival of Biologics (FOB) 2019, Basel 15-17 October 2019

Exiris Human Antibody Phage Display Library for identification of high affinity monoclonal antibodies, without need of further affinity maturation, will be presented at the FOB 2019 https://www.terrapinn.com/conference/festival-of-biologics/index.stm. Details on several... read more →
  • 7th October 2019
  • News

Exiris receives European Union research grant for the ETN MAGICBULLET RELOADED project

Exiris is part of the European Training Network (ETN) MAGICBULLET, which was launched by the European Union in 2015 as part of the HORIZON 2020 program for research and innovation... read more →
  • 24th May 2019
  • News

New data presented at the 35th European Peptide Symposium, 35EPS, Dublin 26th-31st August 2018

Data are presented on novel cryptophycin-based peptide conjugates for tumor targeting, generated in the context of the Horizon 2020 MAGICBULLET project.
  • 26th August 2018
  • News

New data presented at the Peptides and Conjugates for Tumor Targeting, Therapy and Diagnosis, Riminipeptide2018 Congress

Exiris presents data on novel cytotoxic peptide-drug conjugates for tumor targeted therapy, generated in collaboration with the University of Bielefeld and Italfarmaco within the Horizon 2020 MAGICBULLET project. Two lectures... read more →
  • 16th June 2018
  • News

Exiris is awarded a grant from Regione Lazio LIFE 2020

Project funded by   Project: Therapeutic Antibody Service Technologies Description of the project. The TASTE project aims to develop technological services based on... read more →
  • 28th January 2018
  • News

Exiris files patent application on novel cancer therapeutic antibodies

Exiris, in collaboration with the Italian Institute of Health (ISS), Rome and with Aldevron Freiburg Germany, has generated a novel antibody that shows efficacy against colon cancer stem cell and... read more →
  • 16th August 2017
  • News

New data presented at the 7th Annual World ADC Berlin 2017

Data are presented on novel cryptophycin-based antibody- and peptide-drug conjugates for tumor targeted therapy, generated in collaboration with the University of Bielefeld
  • 20th February 2017
  • News
  • 1
  • 2

Next Page »

Latest News

  • Exiris a Maker Faire Roma 2024
  • Interview with Paola Gallinari on “Osservatorio medico-scientifico”
  • Exiris @ RaiNews24
  • Exiris presents a “High Complexity-High Efficiency Human Antibody Phage Display Library” at the Festival of Biologics (FOB) 2019, Basel 15-17 October 2019
  • Exiris receives European Union research grant for the ETN MAGICBULLET RELOADED project
  • New data presented at the 35th European Peptide Symposium, 35EPS, Dublin 26th-31st August 2018
  • New data presented at the Peptides and Conjugates for Tumor Targeting, Therapy and Diagnosis, Riminipeptide2018 Congress
  • Exiris is awarded a grant from Regione Lazio LIFE 2020
  • Exiris files patent application on novel cancer therapeutic antibodies
  • New data presented at the 7th Annual World ADC Berlin 2017
© 2016 Exiris Srl · P.IVA 10897561006